IART Integra LifeSciences Holdings Corporation

Integra LifeSciences to Host Second Quarter 2023 Financial Results Conference Call on July 27, 2023

Integra LifeSciences to Host Second Quarter 2023 Financial Results Conference Call on July 27, 2023

PRINCETON, N.J., July 03, 2023 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release second quarter 2023 financial results on Thursday, July 27, 2023, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register  to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the  following the call.

About Integra LifeSciences

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Aurora®, Bactiseal®, BioD™, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, DuraSorb®, Gentrix®, ICP Express®, Integra®, Licox®, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, NeuraGen®, NeuraWrap™, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit .

Investor Relations:

Chris Ward

(609) 772-7736

   

Media Contact:

Laurene Isip

(609) 208-8121



EN
03/07/2023

Underlying

IARTIntegra LifeSciences Holdings Corporation

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Integra LifeSciences Holdings Corporation

 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Present at the 2024 Bank of America Healthcare...

Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2024 Bank of America Healthcare conference on Tuesday, May 14, 2024 at 4:40pm ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at . About Integra LifeSciencesAt Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate t...

May 13, 2024 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Reports First Quarter 2024 Financial Results

Integra LifeSciences Reports First Quarter 2024 Financial Results PRINCETON, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2024. First Quarter 2024 Highlights First quarter revenues of $368.9 million declined 3.1% on a reported basis and declined 2.5% on an organic basis compared to the prior year. Revenue increased 1.6% on an organic basis excluding BostonFirst quarter GAAP earnings per diluted share of $(0.04), compared to $0.29 in the prior year; adjusted ear...

May 6, 2024 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP...

Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting Visit the Codman Specialty Surgical booth to learn how the CereLink ICP Monitoring System provides patients with uncompromised advanced continuous ICP monitoring. PRINCETON, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, is pleased to announce that following a successful Q1 2024 U.S. relaunch of its , the innovative product will be featured at the upcoming AA...

April 30, 2024 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Reschedule the First Quarter 2024 Financial Re...

Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024 PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. EDT. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the ...

April 18, 2024 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Completes the Acquisition of Acclarent, Inc.

Integra LifeSciences Completes the Acquisition of Acclarent, Inc. PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of , a pioneer in ear, nose and throat (ENT) surgical interventions. The addition of Acclarent's innovative product portfolio expands the breadth of Integra’s market-leading brands and provides immediate scale and accretive growth via a dedicated sales channel. The acquisition adds $1 billion to the total addressable market of the Company’s offerings, ...

April 1, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch